A lot of backpedaling by some
was all about ces launch of gen 4,
oems which would build on the back of the nearly 5000 pos
sure you can’t launch a medical device without dad approval, but the mantra was its in production already , feedback issue wasn’t an issue and come ces deals would be done
now it’s not approved and it was a showing
non of that mentioned in the lead up to capital raising, in fact when the capital raising was so poorly supported and came up short - forget that here comes ces , gen4 and some oem deals
Cash balance doesn’t support another 6 -9 months approval wait time- will all be eaten by insane executive salaries and more will be needed for manufacturing and launch- so get ready for more dilution, secured creditor is owed 2.5 million - all they got is gen 2 rebadged gen3 with Hp on it and a non approved gen 4 single chip bud which isn’t being sold or even manufactured yet because it’s not approved by fda yet
- Forums
- ASX - By Stock
- NUH
- Expected Revenue
Expected Revenue, page-310
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NUH (ASX) to my watchlist
|
|||||
Last
8.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $21.91M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
NUH (ASX) Chart |
Day chart unavailable
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online